Introduction – Company Background
GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.
With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.
With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.
From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.
At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.
By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.
Core Strengths in Insole Manufacturing
At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.
Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.
We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.
With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.
Customization & OEM/ODM Flexibility
GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.
Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.
With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.
Quality Assurance & Certifications
Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.
We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.
Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.
ESG-Oriented Sustainable Production
At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.
To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.
We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.
Let’s Build Your Next Insole Success Together
Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.
From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.
Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.
🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw
Ergonomic insole ODM production factory Taiwan
Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.
With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Graphene cushion OEM factory in Taiwan
Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.
We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Latex pillow OEM production in China
At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Ergonomic insole ODM support China
📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.ODM pillow for sleep brands Indonesia
Researchers at Washington University have discovered that brain inflammation can cause muscle dysfunction by releasing a protein that travels to the muscles, impairing their function. In experiments with fruit flies and mice, they found that this protein reduces energy production in muscle mitochondria. The research also identified possible ways to block this process, which could help treat or prevent muscle wasting in conditions like bacterial infections, Alzheimer’s, and long COVID. Credit: SciTechDaily A study reveals that brain inflammation leads to the release of a protein that impairs muscle function, suggesting potential treatments for related muscle fatigue in diseases like Alzheimer’s and long COVID. Infections and neurodegenerative diseases are known to cause brain inflammation. However, patients with brain inflammation often develop muscle problems that are seemingly independent of the central nervous system. Now, researchers at Washington University School of Medicine in St. Louis have found that brain inflammation releases a specific protein that travels from the brain to the muscles, causing a decline in muscle function. The study, conducted with fruit flies and mice, has also identified ways to block this process. This could have significant implications for treating or preventing the muscle wasting often seen in inflammatory diseases such as bacterial infections, Alzheimer’s disease, and long COVID. Discovering Pathways from Brain to Muscle “We are interested in understanding the very deep muscle fatigue that is associated with some common illnesses,” said senior author Aaron Johnson, PhD, an associate professor of developmental biology. “Our study suggests that when we get sick, messenger proteins from the brain travel through the bloodstream and reduce energy levels in skeletal muscle. This is more than a lack of motivation to move because we don’t feel well. These processes reduce energy levels in skeletal muscle, decreasing the capacity to move and function normally.” In their study, recently published in Science Immunology, the researchers investigated the effects of brain inflammation on muscle function by modeling three diseases: an E. coli bacterial infection, a SARS-CoV-2 viral infection, and Alzheimer’s. When the brain is exposed to inflammatory proteins characteristic of these diseases, damaging chemicals called reactive oxygen species build-up. The reactive oxygen species cause brain cells to produce an immune-related molecule called interleukin-6 (IL-6), which travels throughout the body via the bloodstream. The researchers found that IL-6 in mice — and the corresponding protein in fruit flies — reduced energy production in muscles’ mitochondria, the energy factories of cells. Research from Washington University School of Medicine in St. Louis reveals how brain inflammation triggers extreme muscle weakness across several diseases, including viral infection, bacterial infection and Alzheimer’s disease. Shown are fruit fly muscles; the violet staining is a measure of how well mitochondria in muscle cells are producing energy. On the left is a healthy muscle, and on the right is a muscle exposed to IL-6, an immune-related molecule produced by the brain in response to infections or chronic disease. Credit: Shuo Yang Impact of Disease Proteins on Muscle Performance “Flies and mice that had COVID-associated proteins in the brain showed reduced motor function — the flies didn’t climb as well as they should have, and the mice didn’t run as well or as much as control mice,” Johnson said. “We saw similar effects on muscle function when the brain was exposed to bacterial-associated proteins and the Alzheimer’s protein amyloid beta. We also see evidence that this effect can become chronic. Even if an infection is cleared quickly, the reduced muscle performance remains many days longer in our experiments.” Johnson, along with collaborators at the University of Florida and first author Shuo Yang, PhD — who did this work as a postdoctoral researcher in Johnson’s lab — make the case that the same processes are likely relevant in people. For instance, the bacterial brain infection meningitis is known to increase IL-6 levels and can be associated with muscle issues in some patients. Among COVID-19 patients, inflammatory SARS-CoV-2 proteins have been found in the brain during autopsy, and many long COVID patients report extreme fatigue and muscle weakness even long after the initial infection has cleared. Patients with Alzheimer’s disease also show increased levels of IL-6 in the blood as well as muscle weakness. Potential Treatments and Clinical Implications The study pinpoints potential targets for preventing or treating muscle weakness related to brain inflammation. The researchers found that IL-6 activates what is called the JAK-STAT pathway in muscle, and this is what causes the reduced energy production of mitochondria. Several therapeutics already approved by the Food and Drug Administration for other diseases can block this pathway. JAK inhibitors as well as several monoclonal antibodies against IL-6 are approved to treat various types of arthritis and manage other inflammatory conditions. “We’re not sure why the brain produces a protein signal that is so damaging to muscle function across so many different disease categories,” Johnson said. “If we want to speculate about possible reasons this process has stayed with us over the course of human evolution, despite the damage it does, it could be a way for the brain to reallocate resources to itself as it fights off disease. We need more research to better understand this process and its consequences throughout the body. In the meantime, we hope our study encourages more clinical research into this pathway and whether existing treatments that block various parts of it can help the many patients who experience this type of debilitating muscle fatigue.” Funding: This work is supported by the National Institutes of Health (NIH), the National Key Research and Development Plan of China, the National Natural Science Foundation of China, the Shenzhen San-Ming Project for Prevention and Research on Vector-borne Disease, the New Cornerstone Science Foundation through the New Cornerstone Investigator Program, the Xplorer Prize from Tencent Foundation, the Natural Science Foundation of Heilongjiang Province, the Science Fund Program for Distinguished Young Scholars (Overseas), and the Shenzhen Bay Laboratory Startup Fund. Reference: “Infection and chronic disease activate a systemic brain-muscle signaling axis” by Shuo Yang, Meijie Tian, Yulong Dai, Rong Wang, Shigehiro Yamada, Shengyong Feng, Yunyun Wang, Deepak Chhangani, Tiffany Ou, Wenle Li, Xuan Guo, Jennifer McAdow, Diego E. Rincon-Limas, Xin Yin, Wanbo Tai, Gong Cheng and Aaron Johnson, 12 July 2024, Science Immunology. DOI: 10.1126/sciimmunol.adm7908 Funding: This work is supported by the National Institutes of Health (NIH), the National Key Research and Development Plan of China, the National Natural Science Foundation of China, the Shenzhen San-Ming Project for Prevention and Research on Vector-borne Disease, the New Cornerstone Science Foundation through the New Cornerstone Investigator Program, the Xplorer Prize from Tencent Foundation, the Natural Science Foundation of Heilongjiang Province, the Science Fund Program for Distinguished Young Scholars (Overseas), and the Shenzhen Bay Laboratory Startup Fund.
The rice coral Montipora capitata in waters near the Hawai’i Institute of Marine Biology on Moku o Loʻe in Kāne’ohe Bay, Hawaii. Credit: D. Bhattacharya How to Identify Heat-Stressed Corals Researchers have found a novel way to identify heat-stressed corals, which could help scientists pinpoint the coral species that need protection from warming ocean waters linked to climate change, according to a Rutgers-led study. “This is similar to a blood test to assess human health,” said senior author Debashish Bhattacharya, a Distinguished Professor in the Department of Biochemistry and Microbiology in the School of Environmental and Biological Sciences at Rutgers University–New Brunswick. “We can assess coral health by measuring the metabolites (chemicals created for metabolism) they produce and, ultimately, identify the best interventions to ensure reef health. Coral bleaching from warming waters is an ongoing worldwide ecological disaster. Therefore, we need to develop sensitive diagnostic indicators that can be used to monitor reef health before the visible onset of bleaching to allow time for preemptive conservation efforts.” Coral reefs provide habitat, nursery, and spawning grounds for fish, food for about 500 million people along with their livelihoods, and coastline protection from storms and erosion. But global climate change threatens corals by warming ocean waters, resulting in coral bleaching and disease. Other threats to corals include sea-level rise, a more acidic ocean, unsustainable fishing, damage from vessels, invasive species, marine debris, and tropical cyclones, according to the National Oceanic and Atmospheric Administration. The study, published in the journal Science Advances, examined how Hawaiian stony corals respond to heat stress, with a goal of identifying chemical (metabolite) indicators of stress. Heat stress can lead to the loss of algae that live in symbiosis with corals, resulting in a white appearance (bleaching) and, potentially, the loss of reefs. Scientists subjected the heat-resistant Montipora capitata and heat-sensitive Pocillopora acuta coral species to several weeks of warm seawater in tanks at the Hawaiʻi Institute of Marine Biology. Then they analyzed the metabolites produced and compared them with other corals not subjected to heat stress. “Our work, for the first time, identified a variety of novel and known metabolites that may be used as diagnostic indicators for heat stress in wild coral before or in the early stages of bleaching,” Bhattacharya said. The scientists are validating their coral diagnosis results in a much larger study and the results look promising. The scientists are also developing a “coral hospital” featuring a new lab-on-a-chip device, which could check coral health in the field via metabolite and protein indicators. Reference: “Metabolomic shifts associated with heat stress in coral holobionts” by Amanda Williams, Eric N. Chiles, Dennis Conetta, Jananan S. Pathmanathan, Phillip A. Cleves, Hollie M. Putnam, Xiaoyang Su and Debashish Bhattacharya, 1 January 2021, Science Advances. DOI: 10.1126/sciadv.abd4210 The coral hospital work is in collaboration with Rutgers School of Engineering Professor Mehdi Javanmard and Xiaoyang Su, an assistant professor at Rutgers Robert Wood Johnson Medical School and director of the Rutgers Metabolomics Shared Resource at the Rutgers Cancer Institute of New Jersey. Rutgers co-lead authors for the Hawaii study include doctoral student Amanda Williams and Eric N. Chiles, research teaching specialist at Rutgers Cancer Institute of New Jersey. Other Rutgers co-authors include Jananan S. Pathmanathan, a post-doctoral associate, and Professor Su. Researchers at the University of Rhode Island and Stanford University contributed to the study.
Researchers found an unexpected genetic variation in a new protist species, challenging established understanding of DNA-to-protein translation and emphasizing the mysteries that nature still holds. Scientists testing a new method of sequencing single cells have unexpectedly changed our understanding of the rules of genetics. The genome of a protist has revealed a seemingly unique divergence in the DNA code signaling the end of a gene, suggesting the need for further research to better understand this group of diverse organisms. Dr. Jamie McGowan, a postdoctoral scientist at the Earlham Institute, analyzed the genome sequence of a microscopic organism – a protist – isolated from a freshwater pond at Oxford University Parks. The work was intended to test a DNA sequencing pipeline to work with very small amounts of DNA, such as DNA from a single cell. Dr. McGowan was working with a team of scientists at the Earlham Institute and with Professor Thomas Richards’ group at the University of Oxford. Unexpected Genetic Findings in Protists However, when researchers looked at the genetic code, the protist Oligohymenophorea sp. PL0344 turned out to be a novel species with an unlikely change in how its DNA is translated into proteins. Dr. McGowan said: “It’s sheer luck we chose this protist to test our sequencing pipeline, and it just shows what’s out there, highlighting just how little we know about the genetics of protists.” It is hard to make any statements about protists as a group. Most are microscopic, single-celled organisms like amoebas, algae, and diatoms, but larger multicellular protists exist – such as kelp, slime molds, and red algae. “The definition of a protist is loose – essentially it is any eukaryotic organism which is not an animal, plant, or fungus,” said Dr. McGowan. “This is obviously very general, and that’s because protists are an extremely variable group. “Some are more closely related to animals, some more closely related to plants. There are hunters and prey, parasites and hosts, swimmers, and sitters, and there are those with varied diets while others photosynthesize. Basically, we can make very few generalizations.” Ciliates and Genetic Code Variations Oligohymenophorea sp. PL0344 is a ciliate. These swimming protists can be seen with a microscope and are found almost anywhere there is water. Ciliates are hotspots for genetic code changes, including reassignment of one or more stop codons – the codons TAA, TAG, and TGA. In virtually all organisms, these three stop codons are used to signal the end of a gene. Variations in the genetic code are extremely rare. Among the few variants of the genetic code reported to date, the codons TAA and TAG virtually always have the same translation, suggesting that their evolution is coupled. “In almost every other case we know of, TAA and TAG change in tandem,” explained Dr. McGowan. “When they aren’t stop codons, they each specify the same amino acid.” DNA Translation Anomalies DNA is like a blueprint of a building. It does not do anything in and of itself – it provides instructions for work to be done. In order for a gene to have an impact, the blueprint must be “read” and then built into a molecule which has a physical effect. For DNA to be read, it is first transcribed into an RNA copy. This copy is taken to another area of the cell where it is translated into amino acids, which are combined to make a three-dimensional molecule. The translation process starts at the DNA start codon (ATG) and finishes at a stop codon (normally TAA, TAG, or TGA). In Oligohymenophorea sp. PL0344, only TGA functions as a stop codon – although Dr. McGowan found there are more TGA codons than expected in the ciliate’s DNA, believed to compensate for the loss of the other two. Instead, TAA specifies lysine and TAG specifies glutamic acid. “This is extremely unusual,” Dr. McGowan said. “We’re not aware of any other case where these stop codons are linked to two different amino acids. It breaks some of the rules we thought we knew about gene translation – these two codons were thought to be coupled. “Scientists attempt to engineer new genetic codes – but they are also out there in nature. There are fascinating things we can find, if we look for them. “Or, in this case, when we are not looking for them.” Reference: “Identification of a non-canonical ciliate nuclear genetic code where UAA and UAG code for different amino acids” by Jamie McGowan, Estelle S. Kilias, Elisabet Alacid, James Lipscombe, Benjamin H. Jenkins, Karim Gharbi, Gemy G. Kaithakottil, Iain C. Macaulay, Seanna McTaggart, Sally D. Warring, Thomas A. Richards, Neil Hall and David Swarbreck, 5 October 2023, PLOS Genetics. DOI: 10.1371/journal.pgen.1010913 This research was funded by the Wellcome Trust as part of the Darwin Tree of Life Project, and supported by the Earlham Institute’s core funding from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI.
DVDV1551RTWW78V
Ergonomic insole ODM support China 》empowering smart brands through better materials and processHigh-performance graphene insole OEM Taiwan 》meeting your quality standards, exceeding your expectationsInnovative insole ODM solutions in Taiwan 》driving your product success through every stage of manufacturing
